Hexarelin: Dosage, Benefits & Side Effects

By Peptide Assistant Editorial Team · · · 9 sources cited

Overview

Hexarelin is a synthetic hexapeptide growth hormone secretagogue and one of the most potent GHRPs, stimulating GH more strongly than GHRH or GHRP-6 in human studies. It acts through the ghrelin receptor and, in animal studies, has cardiac effects independent of GH release, mediated by CD36. However, it is prone to desensitization with continuous use.

Mechanism of Action

Hexarelin acts at the GHS-R1a receptor and stimulates GH more strongly than GHRH or GHRP-6 in human studies. In the dose-response study in healthy men, mean peak GH was 26.9, 52.3 and 55.0 ng/ml after 0.5, 1 and 2 mcg/kg intravenously, with the response close to maximal at the top dose. Beyond the pituitary, hexarelin binds CD36 on cardiomyocytes and microvascular endothelium, which is how its cardiac actions are mediated: in perfused rat hearts CD36 activation by hexarelin raised coronary perfusion pressure, an effect absent in CD36-null hearts, and in mice after coronary ligation hexarelin preserved left ventricular function and reduced interstitial collagen. These are animal findings. Hexarelin also raises prolactin, ACTH and cortisol: repeated nighttime injections in volunteers increased all three, where ipamorelin raised neither ACTH nor cortisol in animal studies, though intranasal and oral hexarelin left cortisol and prolactin unchanged in elderly subjects. Its GH effect also fades partly with daily use: twice-daily injections for 16 weeks roughly halved the GH response, which recovered four weeks after stopping.

Hexarelin Benefits: What the Research Shows

  • In the human dose-response study (Imbimbo et al., 1994, European Journal of Clinical Pharmacology), mean peak GH reached 55 ng/ml after 2 mcg/kg intravenously, close to the maximal response, and hexarelin stimulated GH more strongly than GHRH or GHRP-6 in later work
  • Bodart et al. (2002, Circulation Research) identified CD36 as the cardiac binding protein for hexarelin, independent of the ghrelin receptor; in perfused rat hearts its activation raised coronary perfusion pressure, and the effect was absent in CD36-null mice
  • Desensitization studies showed the GH response to twice-daily subcutaneous hexarelin fell by about half over 16 weeks in healthy elderly subjects and returned to baseline four weeks after stopping (Rahim and Shalet, 1998, Growth Hormone & IGF Research)
  • In mice after coronary artery ligation, three weeks of hexarelin improved left ventricular function and reduced interstitial collagen, TGF-beta1 expression and markers of cardiomyocyte injury
  • In adults, low-dose hexarelin given with GHRH was as sensitive as the insulin tolerance test for diagnosing GH deficiency, with a mean GH peak of 83.6 microg/l in healthy subjects against 2.6 microg/l in hypopituitary patients

Hexarelin Dosage

  • Standard dose: 100–200 mcg subcutaneous injection, 1–2 times daily
  • Cardioprotective protocol: 100 mcg twice daily for 4 weeks, then 4 weeks off
  • GH stimulation: 200 mcg pre-bedtime for enhanced nocturnal GH pulse
  • Diagnostic use: hexarelin 0.25 mcg/kg IV together with GHRH 1 mcg/kg IV, the published test for adult GH reserve
  • Cycle strictly: 4–8 weeks on, 4–8 weeks off due to desensitization
  • Combine with CJC-1295 (no DAC) for synergistic GH release during active phase
  • Avoid doses above 200 mcg — cortisol and prolactin elevation increases without proportional GH benefit
Peptide calculator: get your dose in syringe units →

Disclaimer: Dosing information is compiled from research literature and community protocols for educational purposes only. This is not medical advice. Always consult a qualified healthcare provider before starting any peptide protocol.

Hexarelin Side Effects & Safety

Known Side Effects

  • ACTH and cortisol elevation — repeated nighttime injections raised both in healthy volunteers, while intranasal and oral dosing left cortisol unchanged in elderly subjects
  • Prolactin increase — prolactin rose across the night after repeated injections in healthy volunteers; no head-to-head comparison with GHRP-2 or GHRP-6 exists
  • Water retention and facial puffiness, especially in the first 2 weeks
  • Increased appetite — expected from ghrelin receptor activation, though no human study has compared appetite effects across the GHRPs
  • Desensitization of GH response with continuous use beyond 4–8 weeks
  • Tingling, flushing, and dizziness post-injection
  • Injection site irritation

Safety Profile

Hexarelin has been studied in clinical trials and is well-tolerated at standard doses for short-term use. Its main limitation is rapid desensitization — the GH-releasing effect diminishes with continuous use, necessitating strict cycling. The more pronounced cortisol and prolactin elevations compared to other GHRPs make it a less popular choice for long-term protocols. Its cardiac effects have been shown only in animals, and the study that identified its cardiac target found that CD36 activation raised coronary perfusion pressure, which the authors linked to coronary vasospasm. Contraindications: active malignancy, uncontrolled diabetes, prolactinoma, pregnancy. Monitor cortisol and prolactin levels during use. The longest published human exposure is 16 weeks of twice-daily injections in 12 elderly subjects, where the GH response halved and then recovered after a break, so nothing is known beyond that.

What to Expect

Week 1: Strong GH response, though in the one sleep study repeated nighttime hexarelin reduced stage 4 sleep and EEG delta power rather than improving sleep. Water retention begins. Hunger may increase. Weeks 2–4: Peak GH response period. Body composition improvements begin — increased lean mass, improved recovery. Skin quality improves. Weeks 5–8: GH response begins to diminish (desensitization). Cardioprotective benefits continue. This is when many users choose to cycle off. After cycling off for 4–8 weeks, full GH responsiveness returns for subsequent cycles.

Common Stacks

Storage & Handling

Store lyophilized at 2–8°C for up to 12 months or -20°C for longer storage. Reconstitute with bacteriostatic water. Refrigerate reconstituted solution and use within 4 weeks. Protect from light.

Pricing & Available Variants

$40price range
5mg

Prices sourced from peptides.gg marketplace. Prices may vary.

References

  1. Imbimbo BP, Mant T, Edwards M, et al. Growth hormone-releasing activity of hexarelin in humans. A dose-response study. Eur J Clin Pharmacol. 1994.
  2. Rahim A, Shalet SM. Does desensitization to hexarelin occur? Growth Horm IGF Res. 1998.
  3. Frieboes RM, Antonijevic IA, Held K, et al. Hexarelin decreases slow-wave sleep and stimulates the secretion of GH, ACTH, cortisol and prolactin during sleep in healthy volunteers. Psychoneuroendocrinology. 2004.
  4. Bodart V, Febbraio M, Demers A, et al. CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart. Circ Res. 2002.
  5. McDonald H, Peart J, Kurniawan N, et al. Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction. Physiol Rep. 2018.
  6. Gasperi M, Aimaretti G, Scarcello G, et al. Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. J Clin Endocrinol Metab. 1999.
  7. Ghigo E, Arvat E, Gianotti L, et al. Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human aging. Eur J Endocrinol. 1996.
  8. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998.
  9. Berlanga-Acosta J, Abreu-Cruz A, Herrera DGB, et al. Synthetic Growth Hormone-Releasing Peptides (GHRPs): A Historical Appraisal of the Evidences Supporting Their Cytoprotective Effects. Clin Med Insights Cardiol. 2017.

Related Peptides

Track Hexarelin in Your Protocol

Log your Hexarelin doses, track consistency, and monitor your protocol with Peptide Assistant — completely free.

Start Tracking Free